ICF assisted ASPR
in the initial conceptualization and requirements gathering process, build out and launch of TRACIE in 2015.
As a division of ASPR, BARDA takes a comprehensive integrated portfolio approach to advanced research and development, innovation, acquisition, and manufacturing of vaccines, drugs, diagnostic tools, and non-pharmaceutical products for public health emergency threats.
ASPR leads HHS in preparing the nation to respond to and recover from adverse health effects of emergencies, supporting communities ability to withstand adversity, strengthening health and response systems, and enhancing national health security.
Rather than a standard agreement, ASPR
and Regeneron will collaborate using an Other Transaction Agreement (OTA) under authority granted to HHS under the Pandemic and All Hazards Preparedness Act of 2006.
In December 2010, ASPR
, CDC, and other federal partners began developing strategies to better align grants with public health and health care preparedness components.
ASPR partners with other federal agencies, in particular the National Institutes of Health, as well as private industry to develop medical products needed to minimize the health effects of disasters and other public health emergencies.
ASPR lead HHS in preparing the nation to respond to and recover from adverse health effects of emergencies, supporting communities ability to withstand adversity, strengthening health and response systems, and enhancing national health security.
The Pandemic and All-Hazards Preparedness Act I authored with Senator Ted Kennedy (D-MA), and the Pandemic and All-Hazards Reauthorization Act I authored with Senator Robert Casey (D-PA) provide the ASPR with necessary tools to protect Americans against public health threats we may face, whether naturally occurring or the result of a deliberate attack.
Bobs service to our country as an Air Force veteran and a physician make him well positioned to bring a deep understanding of the daily focus and urgency necessary to fulfill the role of the ASPR in leveraging these tools and managing our nations emergency preparedness and response capabilities.
Under the previous ASPR
contract, BPS developed a process to scale up manufacturing of V920 to produce large quantities of the vaccine.
coordinates with other federal agencies, in particular the NIH, and partners with private industry to develop medical products needed to mitigate the health effects of disasters and other public health emergencies.
Biomedical Advanced Research and Development Authority (BARDA) will use authority granted under the Project BioShield Act of 2004 to support the tests late-stage development and potentially purchase tests from one or more of the companies for the Strategic National Stockpile.